Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
Truist Securities analyst Richard Newitter maintains Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $62 to $78.
Stocks · News reference
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60
JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65
Barclays analyst Christopher Pasquale initiates coverage on Inspire Medical Systems (NYSE:INSP) with a Underweight rating and announces Price Target of $65.
Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight
The global bioelectronic medicine market is projected to grow from USD 8.9 billion in 2025 to USD 21.6 billion by 2034, driven by increasing adoption of neuromodulation technologies, advances in implantable devices, AI integration, and expanding applications beyond neurological disorders. North America leads the market with 44% share, while Asia-Pacific is expected to record the fastest growth rate.
Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes